Cepizon-T 2.25G Injection
Marketer
Strathspey Labs Pvt Ltd
Salt Composition
Cefepime (2000mg) + Tazobactum (250mg)
Overview Cepizon-T 2.25G Injection
Ceftibuten and Sulbactam injection, 2.25 grams, combines two antibiotics to combat diverse bacterial infections. Its mechanism involves inhibiting microbial proliferation. Administration must be overseen by a medical professional; adhere strictly to the prescribed schedule and complete the full course, regardless of symptom improvement. Commonly reported side effects include gastrointestinal upset (nausea, vomiting, diarrhea), skin rashes, and localized injection site reactions (redness, swelling, pain), typically resolving spontaneously. Severe or persistent adverse effects necessitate immediate medical attention. Allergic reactions (rash, itching, swelling, respiratory distress) demand urgent medical care. Inform your physician of all concurrent medications, and pregnant or lactating individuals should seek medical counsel prior to use. Alcohol consumption should be avoided due to potential for increased drowsiness. While generally not impairing driving ability, refrain from driving if experiencing somnolence or dizziness.
Uses of Cepizon-T 2.25G Injection
Infections caused by bacteria
Major Benefits of Cepizon-T 2.25G Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Cepizon-T 2.25G Injection:
- Diarrhea
- Increased white blood cell count (eosinophils)
- Injection site phlebitis
- Skin rash
- Increased liver enzymes
- Positive Coombs test
How to use Cepizon-T 2.25G Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
How Cepizon-T 2.25G Injection works:
Cepizon-T 2.25G Injection unites Cefepime, an antibiotic, with Tazobactum, a beta-lactamase inhibitor. Cefepime's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial viability. Tazobactum counteracts bacterial enzymes that would otherwise neutralize Cefepime, thus broadening Cefepime's effectiveness and overcoming bacterial resistance.
SAFETY ADVICE
AlcoholCAUTION
Use of alcohol with Cepizon-T 2.25G Injection requires careful consideration. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The injectable medication Cepizon-T 2.25G is typically deemed safe for use during gestation. Preclinical trials using animals have revealed minimal or absent negative impacts on fetal development; nevertheless, data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Cepizon-T 2.25G is considered safe for use while breastfeeding. Research in humans indicates minimal drug transfer into breast milk, posing no known risk to the infant.
DrivingUNSAFE
Following administration of Cepizon-T 2.25G Injection, temporary blurred vision may occur. Refrain from driving until your vision returns to normal.
KidneyCAUTION
Administering Cepizon-T 2.25G Injection requires careful consideration in individuals with impaired renal function. Dosage modification of Cepizon-T 2.25G Injection might be necessary. Medical supervision is advised.
LiverSAFE IF PRESCRIBED
The use of Cepizon-T 2.25G Injection in patients with hepatic impairment appears to pose minimal risk. Preliminary findings indicate that dosage modification may be unnecessary. However, physician consultation is recommended.
What if you forget to take Cepizon-T 2.25G Injection :
Should you forget a scheduled dose of Cepizon-T 2.25G Injection, seek medical advice.
Facts to Know About Cepizon-T 2.25G Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently